Indian firm Ajanta fails on manufacturing norms, finds WHO
This article was originally published in Scrip
Executive Summary
The World Health Organization has issued a warning letter (notice of concern) to the Indian firm Ajanta Pharma, finding "major deviations" in good manufacturing practice at its Paithan site in Maharashtra.